Format

Send to

Choose Destination
Am J Respir Crit Care Med. 2008 Oct 15;178(8):832-7. doi: 10.1164/rccm.200802-258OC. Epub 2008 Jun 26.

Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study.

Author information

1
Research and Education Unit, Dust Disease Board, Level 2, 82 Elizabeth Street, Sydney, NSW 2000, Australia.

Abstract

RATIONALE:

Soluble mesothelin-related protein (SMRP) is raised in epithelial-type malignant mesothelioma (MM), but the utility of SMRP in screening for MM is unknown.

OBJECTIVES:

We aimed to evaluate SMRP in an asbestos-exposed cohort.

METHODS:

A total of 538 subjects were studied. Those with elevated SMRP (> or =2.5 nM) underwent further investigation including positron emission tomography/computed tomography.

MEASUREMENTS AND MAIN RESULTS:

Mean (+/-SD) SMRP in healthy subjects exposed to asbestos (n = 223) was 0.79 (+/-0.45) nM. Fifteen subjects had elevated SMRP, of whom one had lung cancer, which was successfully resected. Another with lung cancer was undetected by SMRP. No subjects were diagnosed with MM. Mean SMRP in healthy subjects was significantly lower than in subjects with pleural plaques alone (P < 0.01).

CONCLUSIONS:

This is the first large-scale prospective study of SMRP for screening for malignancy in asbestos-exposed individuals. A high false-positive rate was observed. SMRP seems unlikely to prove useful in screening for MM.

Comment in

PMID:
18583574
DOI:
10.1164/rccm.200802-258OC
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center